CHARACTERISTICS OF PROCARBAZINE AS AN INHIBITOR INVITRO OF RAT SEMICARBAZIDE-SENSITIVE AMINE OXIDASE

被引:10
|
作者
HOLT, A [1 ]
SHARMAN, DF [1 ]
CALLINGHAM, BA [1 ]
KETTLER, R [1 ]
机构
[1] F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES DEPT,CH-4002 BASEL,SWITZERLAND
关键词
D O I
10.1111/j.2042-7158.1992.tb03652.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Procarbazine (N-isopropyl-alpha-(2-methyl hydrazino)-p-toluamide hydrochloride) inhibited more powerfully the deamination of benzylamine by semicarbazide-sensitive amine oxidase (SSAO) of rat brown adipose tissue than the deamination of 5-hydroxytryptamine and benzylamine by rat liver monoamine oxidase-A or -B activities, respectively. Inhibition of SSAO, but not monoamine oxidase, was time-dependent. Use of metabolic inhibitors, and an enzyme dilution technique, suggested that any conversion of procarbazine to an active species must be as a result of the action of SSAO itself and not of any other enzyme. The non-competitive kinetics and the time-dependence of inhibition were indicative of a suicide interaction between procarbazine and SSAO. The slow reversal of inhibition by dialysis was evidence in favour of the involvement of tight binding, rather than covalent bonding. High concentrations of benzylamine afforded the enzyme significant protection from the action of procarbazine, indicating that the interaction is at or near the active site. If the properties of procarbazine, evident in in-vitro studies, are retained in-vivo, these data suggest that procarbazine might be suitable for the examination of SSAO activities, both in-vivo and ex-vivo.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 50 条
  • [31] SEMICARBAZIDE-SENSITIVE AMINE OXIDASE INHIBITOR INHIBITS EXTRACELLULAR MATRIX DEPOSITION IN KIDNEY FIBROSIS
    Wong, M.
    Zhang, J.
    Saad, S.
    Wong, M. G.
    Pollock, C.
    NEPHROLOGY, 2013, 18 : 51 - 51
  • [32] METHYLAMINE METABOLISM TO FORMALDEHYDE BY VASCULAR SEMICARBAZIDE-SENSITIVE AMINE OXIDASE
    BOOR, PJ
    TRENT, MB
    LYLES, GA
    TAO, M
    ANSARI, GAS
    TOXICOLOGY, 1992, 73 (03) : 251 - 258
  • [33] SEMICARBAZIDE-SENSITIVE AMINE OXIDASE ACTIVITY IN STREPTOZOTOCIN DIABETIC RATS
    HAYES, BE
    CLARKE, DE
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1990, 69 (01): : 71 - 83
  • [34] SILICON-MEDIATED INACTIVATION OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE
    DANZIN, C
    COLLARD, JN
    MARCHAL, P
    SCHIRLIN, D
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (20) : 2363 - 2366
  • [35] Stability of semicarbazide-sensitive amine oxidase in human blood and plasma
    van Dijk, J
    Boomsma, F
    CLINICA CHIMICA ACTA, 1998, 270 (02) : 189 - 194
  • [36] DEAMINATION OF METHYLAMINE BY SEMICARBAZIDE-SENSITIVE AMINE OXIDASE IN HUMAN UMBILICAL ARTERY AND RAT AORTA
    PRECIOUS, E
    GUNN, CE
    LYLES, GA
    BIOCHEMICAL PHARMACOLOGY, 1988, 37 (04) : 707 - 713
  • [37] Some aspects of the pathophysiology of semicarbazide-sensitive amine oxidase enzymes
    Callingham, BA
    Crosbie, AE
    Rous, BA
    CURRENT NEUROCHEMICAL AND PHARMACOLOGICAL ASPECTS OF BIOGENIC AMINES, 1995, 106 : 305 - 321
  • [38] Crystallization of a truncated soluble human semicarbazide-sensitive amine oxidase
    Jakobsson, E
    Nilsson, J
    Källström, U
    Ogg, D
    Kleywegt, GJ
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2005, 61 : 274 - 278
  • [39] Culture medium enhances semicarbazide-sensitive amine oxidase activity
    Trent, MB
    Conklin, DJ
    Boor, PJ
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2002, 38 (09) : 523 - 528
  • [40] Identification of the quinone cofactor in mammalian semicarbazide-sensitive amine oxidase
    Holt, A
    Alton, G
    Scaman, CH
    Loppnow, GR
    Szpacenko, A
    Svendsen, I
    Palcic, MM
    BIOCHEMISTRY, 1998, 37 (14) : 4946 - 4957